|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.12 USD | -0.16% |
|
+3.24% | +8.39% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -8.63x | 4.02x | 3.8x | -7.02x | -6.59x | 2.15B | ||
| 0.6% | 0.68% | 16.94x | 1.97x | 3.69x | 9.97x | 10.92x | 66.56B | ||
| 0.55% | 0.57% | 28.53x | 4.29x | 5.87x | 17.23x | 21.78x | 57.64B | ||
| -.--% | -.--% | 34.88x | 7x | 11.82x | 22.38x | 26.3x | 42.24B | ||
| 3.49% | 3.58% | -43.93x | 2.4x | 3.11x | 9.2x | 10.74x | 39.09B | ||
| -.--% | -.--% | 34.9x | 1.72x | 3.71x | 11.39x | 13.26x | 31.91B | ||
| -.--% | -.--% | -9.24x | 5.42x | 13.4x | -8.22x | -7.78x | 31.65B | ||
| -.--% | -.--% | 16.96x | 3.4x | 3.25x | 9.83x | 9.74x | 23.35B | ||
| -.--% | 0.05% | 53.7x | 5.43x | 5.97x | 40.99x | 38.22x | 18.92B | ||
| -.--% | -.--% | 26.89x | 3.78x | 5.5x | 14.75x | 20.45x | 17.17B | ||
| -.--% | -.--% | -35.48x | -6.16x | 16.45x | -50.02x | -51.98x | 15.12B | ||
| -.--% | -.--% | -123.95x | 12940.15x | 12.65x | -112.04x | -123.11x | 12.57B | ||
| 0.15% | 0.15% | 64.31x | 26.22x | 39.1x | 55.3x | 57.03x | 12.22B | ||
| -.--% | -.--% | 16.75x | - | 3.57x | 13.08x | 15.68x | 11.4B | ||
| -.--% | -.--% | 48.65x | - | - | - | - | 11.06B | ||
| 2.8% | 3.24% | 11.98x | 1.04x | 1.81x | 7.3x | 9.78x | 6.27B | ||
| 1.56% | 1.73% | 14.43x | 1.33x | 2.56x | 6.62x | 8.02x | 5.78B | ||
| -.--% | -.--% | -106.91x | - | - | - | - | 5.24B | ||
| Average | 0.51% | 0.56% | 2.26x | 866.80x | 8.52x | 2.55x | 3.28x | 22.8B | |
| Weighted average by Cap. | 0.58% | 0.61% | 10.29x | 429.06x | 7.59x | 7.75x | 9.21x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















